Brief Report
Version 1
Preserved in Portico This version is not peer-reviewed
Is Novel Coronavirus Novel: Covid-19, A Pandemic or An Endemic?
Version 1
: Received: 31 May 2020 / Approved: 31 May 2020 / Online: 31 May 2020 (21:14:05 CEST)
How to cite: Banerjee, S. Is Novel Coronavirus Novel: Covid-19, A Pandemic or An Endemic?. Preprints 2020, 2020050515. https://doi.org/10.20944/preprints202005.0515.v1 Banerjee, S. Is Novel Coronavirus Novel: Covid-19, A Pandemic or An Endemic?. Preprints 2020, 2020050515. https://doi.org/10.20944/preprints202005.0515.v1
Abstract
We have analysed the death and recovery rate of Covid-19 disease progression. From the analysis, we have argued that the pandemic is over in certain countries (labelled as group-A) and for other countries (labelled as group-B) the disease appears to remain as endemic. Taking into account the serological survey (sero-survey) test results obtained by certain groups and comparing it with herd immunity threshold value one can infer that the low number of infection for group-B is either due to acquired immunity by some previous infection by other coronavirus or due to innate immunity towards this infection. This effect is stronger for group-B to slow the progress of the disease to such an extent resulting in flattening of the disease progression curve compared to group-A.
Keywords
Covid-19; Herd Immunity Threshold; Corona Virus; Innate immunity; flattening the curve; serological survey
Subject
Biology and Life Sciences, Virology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
